Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Shanghai Xiao Fang Pharmaceutical Co Gross Margin %?
Shanghai Xiao Fang Pharmaceutical CoSHSE:603207 +1.72%38 Gross Margin % is 60.92% as of Mar. 2026, which is 6% below its 10-year median of 65.00. GuruFocus rates SHSE:603207 with a GF Score™ of 38/100. The stock has 2 warning signs investors should review. Among 942 Drug Manufacturers companies, Shanghai Xiao Fang Pharmaceutical Co ranks better than 74.42% on this metric.
SHSE:603207's Gross Margin % is ranked better than 74.42% of 942
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs SHSE:603207: 63.80
Shanghai Xiao Fang Pharmaceutical Co had a gross margin of 60.92% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Shanghai Xiao Fang Pharmaceutical Co had a gross margin of 60.92% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Shanghai Xiao Fang Pharmaceutical Co Gross Margin % Related Terms
Shanghai Xiao Fang Pharmaceutical Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Xiao Fang Pharmaceutical Co Gross Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Xiao Fang Pharmaceutical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Xiao Fang Pharmaceutical Co Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai Xiao Fang Pharmaceutical Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Shanghai Xiao Fang Pharmaceutical Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) has a Gross Margin % of 60.92% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Shanghai Xiao Fang Pharmaceutical Co and its competitors. This is near median its historical median of 65.00. Over the past decade, Shanghai Xiao Fang Pharmaceutical Co's Gross Margin % has ranged from 59.04 to 65.61. According to the industry distribution chart, Shanghai Xiao Fang Pharmaceutical Co ranks #241 out of 942 companies in the Drug Manufacturers industry, placing it in the top 25.6%.
Is Shanghai Xiao Fang Pharmaceutical Co's Gross Margin % too high?
Shanghai Xiao Fang Pharmaceutical Co's current Gross Margin % of 60.92% is near median its 10-year median of 65.00. Over the past 10 years, this metric has ranged from a low of 59.04 to a high of 65.61. The Drug Manufacturers industry median Gross Margin % is 48.54. Shanghai Xiao Fang Pharmaceutical Co's value of 60.92% is 25.5% above this industry median. Based on the distribution chart, Shanghai Xiao Fang Pharmaceutical Co ranks #241 out of 942 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Shanghai Xiao Fang Pharmaceutical Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Xiao Fang Pharmaceutical Co's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shanghai Xiao Fang Pharmaceutical Co ranks #241 out of 942 companies for Gross Margin %. This puts Shanghai Xiao Fang Pharmaceutical Co in the upper half of its industry. The industry median Gross Margin % is 48.54. Shanghai Xiao Fang Pharmaceutical Co's value of 60.92% is 25.5% above this benchmark. Historically, Shanghai Xiao Fang Pharmaceutical Co's own Gross Margin % has ranged from 59.04 to 65.61 over the past decade. While the company's 10-year median is 65.00 vs. the industry median of 48.54, Shanghai Xiao Fang Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 942 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Xiao Fang Pharmaceutical Co's current Gross Margin % of 60.92% is 25.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Shanghai Xiao Fang Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Xiao Fang Pharmaceutical Co's current Gross Margin % is 60.92%, which is near median its own 10-year median of 65.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Xiao Fang Pharmaceutical Co stock overvalued right now?
Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) has a current Gross Margin % of 60.92%. The current Gross Margin % is 60.92%, which is near median its 10-year median of 65.00 and 25.5% above the Drug Manufacturers industry median of 48.54. Shanghai Xiao Fang Pharmaceutical Co's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207), the current Gross Margin % is 60.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shanghai Xiao Fang Pharmaceutical Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603207 has been successfully added to your 
